Bioimplant formulation
US6913761B1 · kind B1 · utility
10Cited by
2References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 1999 |
| Grant date | Jul 5, 2005 |
| Priority date | — |
| Expiry date | Jul 20, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical and/or veterinary formulation comprising about 2-30% (w/w) (on an active basis) of at least one active agent, about 0.5-20.0% (w/w) of a pore-foaming agent and the balance stearin. Such formulations provided release of the at least one active agent in humans and other animals for periods of 7 days up to about 2 years.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.